Effect of high-dose intravenous vitamin C on organ support-free days within the first 14 days in severe acute pancreatitis patients: a multicenter, randomized, double-blind, placebo-controlled clinical trial protocol
Authors:
Open Access
- 6 August 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1850105
Abstract
Background: The global incidence of severe acute pancreatitis (SAP) is increasing, yet mortality rates remain persistently high. Novel therapeutic approaches are urgently needed to improve outcomes. The aim of this study is to evaluate the efficacy of high-dose intravenous vitamin C in improving organ support-free days within the first 14 days and other clinical outcomes in patients with SAP. Method: This is a prospective, randomized, double-blind, multicenter clinical trial. Participants will be stratified and randomly assigned to either the HDIVC group or the control group. Data will be analyzed using SAS 9.4 with two-sided tests and a significance threshold of p < 0.05. This study will be conduct at eight hospitals in China, including Shanghai Jiao Tong University School of Medicine Affiliated Ruijin Hospital, Shanghai General Hospital, Changhai Hospital, Sichuan Provincial People’s Hospital, Chongqing Daping Hospital, The Second People’s Hospital of Chengdu, Guanghan People’s Hospital and Chongqing Emergency Medical Center. Eligible patients are adults (age ≥ 18 years) diagnosed with severe acute pancreatitis according to 2012 Atlanta classification within 7 days of onset. HDIVC (500 mg/kg, 2 g/h) or placebo (normal saline) will be administered via central vein for 7 days. The primary outcome is organ support-free days within the first 14 days. Secondary outcomes include ICU all-cause mortality, changes in inflammatory biomarkers, and organ failure scores. Discussion: If proven effective, the results of this trial could establish high-dose intravenous vitamin C as a cost-effective adjunctive therapy to improve survival in patients with severe acute pancreatitis and potentially inform future clinical practice guidelines. Clinical trial registration: ClinicalTrials.gov , identifier NCT06897384.Keywords
This publication has 25 references indexed in Scilit:
- Intravenous Vitamin C in Adults with Sepsis in the Intensive Care UnitNew England Journal of Medicine, 2022
- Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-AnalysisGastroenterology, 2022
- Potential benefit of high-dose intravenous vitamin C for coronavirus disease 2019 pneumoniaChinese Medical Journal, 2021
- Acute pancreatitisThe Lancet, 2020
- Harm of IV High-Dose Vitamin C Therapy in Adult Patients: A Scoping ReviewCritical Care Medicine, 2020
- Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory FailureJAMA, 2019
- Vitamin C Pharmacokinetics in Critically Ill PatientsChest, 2018
- Evaluation of oxidative stress and antioxidant status: Correlation with the severity of sepsisScandinavian Journal of Immunology, 2018
- Vitamin C treatment attenuates hemorrhagic shock related multi-organ injuries through the induction of heme oxygenase-1BMC Complementary and Alternative Medicine, 2014
- SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsBMJ, 2013